Luminex Net Income 2006-2018 | LMNX

Luminex net income from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Luminex Annual Net Income
(Millions of US $)
2018 $18
2017 $29
2016 $14
2015 $37
2014 $39
2013 $7
2012 $12
2011 $14
2010 $5
2009 $18
2008 $3
2007 $-3
2006 $2
2005 $-3
Luminex Quarterly Net Income
(Millions of US $)
Q4 2018 $-3
Q3 2018 $2
Q2 2018 $6
Q1 2018 $13
Q4 2017 $-3
Q3 2017 $18
Q2 2017 $6
Q1 2017 $9
Q4 2016 $-3
Q3 2016 $3
Q2 2016 $6
Q1 2016 $9
Q4 2015 $20
Q3 2015 $6
Q2 2015 $3
Q1 2015 $7
Q4 2014 $23
Q3 2014 $6
Q2 2014 $5
Q1 2014 $6
Q4 2013 $5
Q3 2013 $1
Q2 2013 $4
Q1 2013 $-3
Q4 2012 $4
Q3 2012 $2
Q2 2012 $3
Q1 2012 $4
Q4 2011 $3
Q3 2011 $2
Q2 2011 $5
Q1 2011 $4
Q4 2010 $3
Q3 2010 $-1
Q2 2010 $1
Q1 2010 $2
Q4 2009 $20
Q3 2009 $-1
Q2 2009 $1
Q1 2009 $-3
Q4 2008 $2
Q3 2008 $3
Q2 2008 $-1
Q1 2008 $-1
Q4 2007 $11
Q3 2007 $-2
Q2 2007 $-12
Q1 2007 $0
Q4 2006 $1
Q3 2006 $0
Q2 2006 $0
Q1 2006 $1
Q4 2005 $-1
Q3 2005 $-1
Q2 2005 $-0
Q1 2005 $-0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.067B $0.316B
Luminex Corporation is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP open-architecture, multi-analyte platform and MultiCode real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $105.261B 23.72
Intuitive Surgical (ISRG) United States $64.748B 60.48
Edwards Lifesciences (EW) United States $39.266B 40.21
Fresenius Medical Care AG KGaA (FMS) Germany $23.664B 16.20
IDEXX Laboratories (IDXX) United States $18.872B 51.39
ABIOMED (ABMD) United States $14.572B 96.19
Teleflex (TFX) United States $13.884B 30.44
Hologic (HOLX) United States $13.648B 20.64
Varian Medical Systems (VAR) United States $12.581B 31.43
DexCom (DXCM) United States $11.613B 444.93
STERIS (STE) United Kingdom $10.406B 26.74
Masimo (MASI) United States $7.109B 44.26
Penumbra (PEN) United States $5.474B 309.73
Integra LifeSciences Holdings (IART) United States $4.712B 22.85
Globus Medical (GMED) United States $4.682B 28.42
LivaNova (LIVN) United Kingdom $4.628B 28.53
Wright Medical Group (WMGI) Netherlands $3.980B 0.00
Tandem Diabetes Care (TNDM) United States $3.969B 0.00
Glaukos (GKOS) United States $2.896B 0.00
Cantel Medical (CMD) United States $2.757B 27.42
Integer Holdings (ITGR) United States $2.736B 22.32
Inogen (INGN) United States $1.966B 39.18
AVANOS MEDICAL, INC (AVNS) United States $1.941B 21.08
Nevro (NVRO) United States $1.885B 0.00
OPKO Health (OPK) United States $1.557B 0.00
Pacific Biosciences Of California (PACB) United States $1.102B 0.00
Accelerate Diagnostics (AXDX) United States $1.083B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $1.059B 28.78
Tactile Systems Technology (TCMD) United States $1.045B 198.46
CryoLife (CRY) United States $1.043B 112.44
Veracyte (VCYT) United States $1.006B 0.00
Intersect ENT (XENT) United States $0.968B 0.00
Fluidigm (FLDM) United States $0.938B 0.00
Mesa Laboratories (MLAB) United States $0.875B 35.79
Natus Medical (BABY) United States $0.851B 17.75
AngioDynamics (ANGO) United States $0.811B 26.30
ViewRay (VRAY) United States $0.808B 0.00
AxoGen (AXGN) United States $0.795B 0.00
OrthoPediatrics (KIDS) United States $0.654B 0.00
Quotient (QTNT) Switzerland $0.556B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.462B 48.72
Si-Bone (SIBN) United States $0.440B 0.00
Accuray (ARAY) United States $0.414B 0.00
GenMark Diagnostics (GNMK) United States $0.412B 0.00
Pulse Biosciences (PLSE) United States $0.372B 0.00
RTI Surgical (RTIX) United States $0.357B 52.09
IRadimed (IRMD) United States $0.304B 64.19
SeaSpine Holdings (SPNE) United States $0.282B 0.00
Sientra (SIEN) United States $0.276B 0.00
Neuronetics (STIM) United States $0.262B 0.00
Nuvectra (NVTR) United States $0.206B 0.00
ConforMIS (CFMS) United States $0.162B 0.00
Helius Medical Technologies (HSDT) United States $0.159B 0.00
Ekso Bionics Holdings (EKSO) United States $0.153B 0.00
T2 Biosystems (TTOO) United States $0.129B 0.00
Biosig Technologies (BSGM) United States $0.121B 0.00
Sensus Healthcare (SRTS) United States $0.121B 0.00
SOLITON INC (SOLY) $0.114B 0.00
Alphatec Holdings (ATEC) United States $0.114B 0.00
Second Sight Medical Products (EYES) United States $0.106B 0.00
Vermillion (VRML) United States $0.103B 0.00
Apollo Endosurgery (APEN) United States $0.088B 0.00
EDAP TMS (EDAP) France $0.085B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.073B 0.00
Titan Medical (TMDI) Canada $0.065B 0.00
Ra Medical Systems (RMED) United States $0.050B 0.00
Viveve Medical (VIVE) United States $0.044B 0.00
Avinger (AVGR) United States $0.037B 0.00
OBALON THERPTCS (OBLN) United States $0.037B 0.00
Microbot Medical (MBOT) United States $0.034B 0.00
PAVmed (PAVM) United States $0.028B 0.00
DarioHealth (DRIO) Israel $0.027B 0.00
Restoration Robotics (HAIR) United States $0.027B 0.00
Lianluo Smart (LLIT) China $0.026B 0.00
ENDRA Life Sciences (NDRA) United States $0.021B 0.00
Atossa Genetics (ATOS) United States $0.021B 0.00
Bioanalytical Systems (BASI) United States $0.021B 66.67
Dynatronics (DYNT) United States $0.017B 0.00
ReWalk Robotics (RWLK) Israel $0.016B 0.00
Nanovibronix (NAOV) United States $0.015B 0.00
Presbia (LENS) Ireland $0.012B 0.00
Neovasc (NVCN) Canada $0.012B 0.00
Allied Healthcare Products (AHPI) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00